Publication

Rapid Pneumococcal Evolution in Response to Clinical Interventions

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Nicholas J. Croucher, Wellcome Trust Sanger InstituteSimon R. Harris, Wellcome Trust Sanger InstituteChristophe Fraser, Imperial College LondonMichael A. Quail, Wellcome Trust Sanger InstituteJohn Burton, Wellcome Trust Sanger InstituteMark van der Linden, Rhein Westfal TH AachenLesley McGee, Centers for Disease Control and PreventionAnne von Gottberg, University of WitwatersrandJae Hoon Song, Sungkyunkwan UniversityKwan Soo Ko, Sungkyunkwan UniversityBruno Pichon, Health Protection Agency Centre for InfectionsStephen Baker, Oxford UniversityChristopher M. Parry, Oxford UniversityLotte M. Lambertsen, Statens Serum InstitutDea Shahinas, University of TorontoDylan R. Pillai, University of TorontoTimothy J. Mitchell, University of GlasgowGordon Dougan, Wellcome Trust Sanger InstituteAlexander Tomasz, Rockefeller UniversityKeith Klugman, Emory UniversityJulian Parkhill, Wellcome Trust Sanger InstituteWilliam P. Hanage, Imperial College LondonStephen D. Bentley, Wellcome Trust Sanger Institute
Language
  • English
Date
  • 2011-01-28
Publisher
  • AMER ASSOC ADVANCEMENT SCIENCE
Publication Version
Copyright Statement
  • 2013 American Association for the Advancement of Science.
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 331
Issue
  • 6016
Start Page
  • 430
End Page
  • 434
Grant/Funding Information
  • This work was funded by the Wellcome Trust.
Supplemental Material (URL)
Abstract
  • Epidemiological studies of the naturally transformable bacterial pathogen Streptococcus pneumoniae have previously been confounded by high rates of recombination. Sequencing 240 isolates of the PMEN1 (Spain23F-1) multidrug-resistant lineage enabled base substitutions to be distinguished from polymorphisms arising through horizontal sequence transfer. More than 700 recombinations were detected, with genes encoding major antigens frequently affected. Among these were 10 capsule-switching events, one of which accompanied a population shift as vaccine-escape serotype 19A isolates emerged in the USA after the introduction of the conjugate polysaccharide vaccine. The evolution of resistance to fluoroquinolones, rifampicin, and macrolides was observed to occur on multiple occasions. This study details how genomic plasticity within lineages of recombinogenic bacteria can permit adaptation to clinical interventions over remarkably short time scales.
Author Notes
Keywords
Research Categories
  • Health Sciences, Immunology
  • Biology, Virology

Tools

Relations

In Collection:

Items